Premium
ANALYSIS OF EZH2 MUTATIONS IN SOLID AND LIQUID BIOPSY AND ITS ROLE AS PREDICTIVE BIOMARKER FOR CHEMOTHERAPY IN PATIENTS WITH FOLLICULAR LYMPHOMA
Author(s) -
SanzVillanueva L.,
Díaz Crespo F.,
Martín Rojas R.,
Carbonell D.,
Chicano M.,
SuárezGonzález J.,
Muñiz P.,
Menárguez J.,
Kwon M.,
Diez Martín J. L.,
Buño I.,
MartínezLaperche C.,
Bastos Oreiro M.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.38_2880
Subject(s) - follicular lymphoma , medicine , oncology , liquid biopsy , biopsy , biomarker , plasma cell , sanger sequencing , cancer research , mutation , pathology , lymphoma , biology , gene , cancer , genetics , multiple myeloma